Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORDISSEMINATION IN UNITED STATES CALGARY, Alberta, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Pieridae Energy Limited (“Pieridae” or the “Company”)...
-
MOUNTAIN IRON, Minn., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Heliene Inc., a leading North American solar PV module manufacturer, is pleased to announce closing a strategic equity investment up to $54...
-
This signature event in early-stage investment community will be held on October 31, 2024, at Convene City View in Philadelphia.
-
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has...
-
MARIETTA, Ga., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, awarded more than $170,000 in grants through its Yamaha Outdoor Access Initiative (OAI) in the second quarter of 2024,...
-
CARROLLTON, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- LiquidStack, a global leader in liquid cooling for data centers, today announced that it has secured a $20 million Series B extension investment...
-
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
-
ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...
-
SAN FRANCISCO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Fundbox, a leading embedded capital platform for SMBs, announces a new credit facility with Cross River, a technology infrastructure provider that...
-
Existing investors and new investor Double Point Ventures join forces to support ImmunOs TherapeuticsInvestment secures funding of ongoing promising clinical trial of IOS-1002 in solid cancers ...